Editors' Pick Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lublin F, Miller DH, Freedman MS, Cree BAC, Wolinsky JS, Weiner H, Lubetzki C, Hartung H-P, Montalban X, Uitdehaag B M, et al. Lancet. 2016 Jan 27. Epub 1969 Dec 31. PMID: 26827074. Abstract CommentRecommendBookmarkWatch